BioSpace News Archive

Drug Development

ASCO2016: Gamida Cell Presents Data From Phase 1/2 Study Of Nicord For High Risk Hematological Malignancies At ASCO 2016

June 6, 2016
·
4 min read
Drug Development

ASCO2016: Kite Pharma Presents Ongoing Complete Responses At 9 Months In Phase I Of ZUMA-1 In Patients With Chemorefractory Non-Hodgkin Lymphoma

June 6, 2016
·
5 min read
Finesse Solutions SmartFactory Platform Featured In Alvotech Opening Of New Manufacturing And Lab Facility In Iceland

June 6, 2016
·
3 min read
Drug Development

ASCO2016: SELLAS Life Sciences Group Announces Exciting Results For Galinpepimut-S, The Company’s WT1 Vaccine, In Patients With Acute Myeloid Leukemia (AML) And Malignant Pleural Mesothelioma (MPM), As Presented At The 2016 ASCO Annual Meeting

June 6, 2016
·
8 min read
Policy

Adamis Stock Tanks After the FDA Rejects Emergency Drug for Severe Allergic Reaction

June 6, 2016
·
4 min read
Business

Merck & Co. Partners With Array BioPharma And Pierre Fabre To Initiate BRAF-Mutant CRC Phase III Trial

June 6, 2016
·
7 min read
Drug Development

Array BioPharma Release: Encorafenib-Based Regimens Provide Improved PFS And OS In Difficult-To-Treat BRAF-Mutant Colorectal Cancer Compared To Historical Benchmarks

June 6, 2016
·
6 min read
Drug Development

ASCO2016: Janssen R&D Release: Daratumumab (DARZALEX) Combination Therapy Significantly Extended Progression-Free Survival In Previously Treated Patients With Multiple Myeloma

June 6, 2016
·
16 min read
Drug Development

Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 In Idiopathic Pulmonary Fibrosis

June 6, 2016
·
2 min read
Genetown

Arch Therapeutics Completes Patient Enrollment In Clinical Study Of AC5

June 6, 2016
·
5 min read